Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**DDR1 divergent transcript (DDR1-DT)** is a non-coding RNA gene located in the vicinity of the DDR1 gene on chromosome 6p21.33[3][7]. It is also called DDR1-AS1 (DDR1 antisense RNA 1), TIGD1L, bPG70P20.2, bCX111D4.7, and bQB10J12.1[1][3]. Unlike the protein-coding DDR1 gene, which encodes the discoidin domain receptor 1 — a receptor tyrosine kinase involved in collagen signaling, cell adhesion, and tumor biology[2][4][5][6][8] — DDR1-DT is not known to encode a functional protein and is not considered a therapeutic target. Its biological function is not described in the current scientific literature, and it has no established role as a disease gene, biomarker, or drug target[7]. **Key clarification:** - **DDR1 divergent transcript (DDR1-DT)** should not be conflated with **DDR1 (Discoidin domain receptor 1)**, which is a validated receptor tyrosine kinase and recognized oncology drug target[4][5][8]. - There is no evidence that DDR1-DT is a receptor, enzyme, transporter, or other classical drug target.
None known; not a protein or enzyme, so no mechanism of action for drug interaction is described.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DDR1 divergent transcript (DDR1-DT).